Monthly Archives: July 2015

E

I wanted to share with you some new features and site developments. We believe these new features will make your experience on the site more enjoyable and rewarding. Increased Exposure Our headlines now appear on many additional sites including Zacks, Yahoo Finance, Investing.com, Benzinga, Seeking Alpha, Huffington Post and many others as part of a free…

BP Q2 Hit By Lower Realizations, Misses Earnings Estimates

British energy giant, BP plc (BP – Analyst Report) reported second-quarter 2015 adjusted earnings of 43 cents per American Depositary Share (ADS) on a replacement cost basis, excluding non-operating items. The bottom line came below the Zacks Consensus Estimate of 55 cents and saw a drastic decline from the year-ago earnings of $1.18. BP’s total revenue was $61,800 million…

DuPont’s Earnings Miss On Agriculture Weakness, Cuts View

DuPont‘s (DD – Analyst Report) second-quarter 2015 revenues and earnings missed expectations as weakness in its agriculture business coupled with currency headwinds weighed on its results for the quarter.   DuPont logged adjusted earnings of $1.18 per share in the reported quarter versus $1.17 per share registered a year ago. It fell short of the Zacks Consensus…

Baidu, Inc. (ADR): Earnings Fall Below Expectations, Analysts Rem

Baidu, Inc. (ADR) (NASDAQ:BIDU), a Chinese-language Internet search engine, released its second quarter fiscal 2015 earnings on July 27, performing below analyst consensus expectations. Following the release of their Q2 earnings, Baidu stock fell 12% in value in pre-market trading. While the Street expected the company to post $1.87 earnings per share, Baidu fell short and…

Teva Agrees To Acquire Allergan Generics

Teva Pharmaceutical Industries made big news in the market Monday after announcing that they have come to an agreement to purchase the generic arm of Allergan. Today, we’ll discuss the details of the agreement, what Teva gains from the acquisition, and of course, what we can expect to see moving forward. So, let’s get right to…

The Top 4 Best Analyst Coverage On Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Ltd. (TEVA) is slated to announce second quarter 2015 earnings results on Thursday, July 30, before market open. The company released preliminary Q2 results on July 27, estimating $4.97 billion in revenue and non-GAAP earnings of $1.43 per share. The preliminary earnings raised the company’s full-year 2015 EPS guidance to be in…